Lack of association between B19 or V9 erythrovirus infection and ANCA-positive vasculitides: a case-control study

被引:13
作者
Eden, A
Mahr, A
Servant, A
Radjef, N
Amard, S
Mouthon, L
Garbarg-Chenon, A
Guillevin, L
机构
[1] Univ Paris 13, Hop Avicenne, Dept Internal Med, Unite Rech Clin & Therapeut EA 3409, F-93009 Bobigny, France
[2] Hop Armand Trousseau, Dept Bacteriol Virol, UFR St Antoine, EA 2391, Paris, France
关键词
erythrovirus; B19; V9; ANCA; vasculitis;
D O I
10.1093/rheumatology/keg206
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To examine the potential association of human B19 or V9 erythrovirus infection and onset of ANCA-positive vasculitides. Methods. We tested the sera of 13 adults with newly diagnosed ANCA-positive vasculitides. Each was age- and sex-matched to three sera obtained from healthy controls. All samples were tested for B19- and V9-specific immunoglobulin (Ig) G and IgM antibodies (Ab) (third-generation ELISA), and B19 or V9 DNA was sought with the polymerase chain reaction. Statistical analysis was performed by conditional logistic regression. Results. Patient diagnoses comprised six cases of Wegener's granulomatosis, six of microscopic polyangiitis and one of Churg-Strauss syndrome. IgG Ab to B19 were detected equally in patient and control sera (77 and 79% respectively) (odds ratio=0.84, P=0.84). All 13 cases and 39 controls were negative for IgM Ab and viral DNA. Conclusion. These results suggest that neither acute nor chronic B19 or V9 infection is an aetiological factor in ANCA-associated vasculitides.
引用
收藏
页码:660 / 664
页数:5
相关论文
共 37 条
  • [1] No serological indications that systemic lupus erythematosus is linked with exposure to human parvovirus B19
    Bengtsson, A
    Widell, A
    Elmståhl, S
    Sturfelt, G
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2000, 59 (01) : 64 - 66
  • [2] Brown KE, 1997, MONOGR VIROL, V20, P42
  • [3] EVALUATION OF 5 COMMERCIAL TESTS FOR DETECTION OF IMMUNOGLOBULIN-M ANTIBODIES TO HUMAN PARVOVIRUS-B19
    BRUU, AL
    NORDBO, SA
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (05) : 1363 - 1365
  • [4] Choi HK, 2000, ARTHRITIS RHEUM, V43, P226, DOI 10.1002/1529-0131(200001)43:1<226::AID-ANR27>3.0.CO
  • [5] 2-Q
  • [6] Parvovirus B19 infection associated with the production of anti-neutrophil cytoplasmic antibody (ANCA) and anticardiolipin antibody (aCL)
    Chou, TNK
    Hsu, TC
    Chen, RM
    Lin, LI
    Tsay, GJ
    [J]. LUPUS, 2000, 9 (07) : 551 - 554
  • [7] ASSOCIATION OF WEGENER GRANULOMATOSIS WITH PARVOVIRUS B19 INFECTION - COMMENT
    CORMAN, LC
    STAUD, R
    [J]. ARTHRITIS AND RHEUMATISM, 1995, 38 (08): : 1174 - 1175
  • [8] Elling H, 2000, CLIN EXP RHEUMATOL, V18, pS12
  • [9] Falk RJ, 1997, J AM SOC NEPHROL, V8, P314
  • [10] CHRONIC PARVOVIRUS B19 INFECTION AND SYSTEMIC NECROTIZING VASCULITIS - OPPORTUNISTIC INFECTION OR ETIOLOGIC AGENT
    FINKEL, TH
    TOROK, TJ
    FERGUSON, PJ
    DURIGON, EL
    ZAKI, SR
    LEUNG, DYM
    HARBECK, RJ
    GELFAND, EW
    SAULSBURY, FT
    HOLLISTER, JR
    ANDERSON, LJ
    [J]. LANCET, 1994, 343 (8908) : 1255 - 1258